280 related articles for article (PubMed ID: 26174147)
21. Cost-effectiveness of antimicrobial prophylaxis for children in the RIVUR trial.
Palmer LS; Seideman CA; Lotan Y
World J Urol; 2018 Sep; 36(9):1441-1447. PubMed ID: 29707736
[TBL] [Abstract][Full Text] [Related]
22. Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial prophylaxis really needed?
Islek A; Güven AG; Koyun M; Akman S; Alimoglu E
Pediatr Nephrol; 2011 Oct; 26(10):1837-41. PubMed ID: 21520006
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial.
King W; Homer T; Harding C; Mossop H; Chadwick T; Abouhajar A; Vale L
BMJ Open; 2024 Apr; 14(4):e074445. PubMed ID: 38684270
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of hydrophilic-coated intermittent catheters compared with uncoated catheters in Canada: a public payer perspective.
Welk B; Isaranuwatchai W; Krassioukov A; Husted Torp L; Elterman D
J Med Econ; 2018 Jul; 21(7):639-648. PubMed ID: 29458282
[TBL] [Abstract][Full Text] [Related]
25. Guidelines for urinary tract infections and antenatal hydronephrosis should be gender specific.
Moore SS; Bahat H; Rachmiel M; Ziv-Baran T; Youngster I; Goldman M
Acta Paediatr; 2015 Nov; 104(11):e512-7. PubMed ID: 26173376
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis.
Pearle MS; Roehrborn CG
Urology; 1997 May; 49(5):679-86. PubMed ID: 9145970
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial.
Bosmans JE; Beerepoot MA; Prins JM; ter Riet G; Geerlings SE
PLoS One; 2014; 9(4):e91939. PubMed ID: 24705418
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
[TBL] [Abstract][Full Text] [Related]
29. Resolution rate of isolated low-grade hydronephrosis diagnosed within the first year of life.
Madden-Fuentes RJ; McNamara ER; Nseyo U; Wiener JS; Routh JC; Ross SS
J Pediatr Urol; 2014 Aug; 10(4):639-44. PubMed ID: 25185821
[TBL] [Abstract][Full Text] [Related]
30. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic Prophylaxis for the Prevention of Urinary Tract Infections in Children: Guideline and Recommendations from the Emilia-Romagna Pediatric Urinary Tract Infections (UTI-Ped-ER) Study Group.
Autore G; Bernardi L; Ghidini F; La Scola C; Berardi A; Biasucci G; Marchetti F; Pasini A; Capra ME; Castellini C; Cioni V; Cantatore S; Cella A; Cusenza F; De Fanti A; Della Casa Muttini E; Di Costanzo M; Dozza A; Gatti C; Malaventura C; Pierantoni L; Parente G; Pelusi G; Perrone S; Serra L; Torcetta F; Valletta E; Vergine G; Antodaro F; Bergomi A; Chiarlolanza J; Leoni L; Mazzini F; Sacchetti R; Suppiej A; Iughetti L; Pession A; Lima M; Esposito S; The Uti-Ped-Er Study Group
Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370359
[No Abstract] [Full Text] [Related]
32. Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model.
Eells SJ; Bharadwa K; McKinnell JA; Miller LG
Clin Infect Dis; 2014 Jan; 58(2):147-60. PubMed ID: 24065333
[TBL] [Abstract][Full Text] [Related]
33. Neonatal Circumcision and Urinary Tract Infections in Infants With Hydronephrosis.
Ellison JS; Dy GW; Fu BC; Holt SK; Gore JL; Merguerian PA
Pediatrics; 2018 Jul; 142(1):. PubMed ID: 29880703
[TBL] [Abstract][Full Text] [Related]
34. Urinary tract infections in children with prenatal hydronephrosis: A risk assessment from the Society for Fetal Urology Hydronephrosis Registry.
Zee RS; Herbst KW; Kim C; McKenna PH; Bentley T; Cooper CS; Herndon CD
J Pediatr Urol; 2016 Aug; 12(4):261.e1-7. PubMed ID: 27290614
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Krahn AD; Schloss EJ; Gallastegui JL; Pickett RA; Evonich RF; Roark SF; Sorrentino DM; Sholevar DP; Cronin EM; Berman BJ; Riggio DW; Khan HH; Silver MT; Collier J; Eldadah Z; Holbrook R; Lande JD; Lexcen DR; Seshadri S; Tarakji KG
Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
[TBL] [Abstract][Full Text] [Related]
36. A cost-effectiveness analysis of bacterial endocarditis prophylaxis for febrile children who have cardiac lesions and undergo urinary catheterization in the emergency department.
Caviness AC; Cantor SB; Allen CH; Ward MA
Pediatrics; 2004 May; 113(5):1291-6. PubMed ID: 15121944
[TBL] [Abstract][Full Text] [Related]
37. Cohort study on circumcision of newborn boys and subsequent risk of urinary-tract infection.
To T; Agha M; Dick PT; Feldman W
Lancet; 1998 Dec; 352(9143):1813-6. PubMed ID: 9851381
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source.
Werntz RP; Martinez-Acevedo A; Amadi H; Kopp R; La Rochelle J; Koppie T; Amling C; Sajadi KP
Urol Oncol; 2018 May; 36(5):238.e1-238.e5. PubMed ID: 29338914
[TBL] [Abstract][Full Text] [Related]
39. Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis.
Nateghian AR; Robinson JL; Mohandessi S; Hooman N
J Infect Public Health; 2009; 2(3):147-52. PubMed ID: 20701875
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.
Jansen JP; Kumar R; Carmeli Y
Value Health; 2009; 12(2):234-44. PubMed ID: 20667059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
